Cargando…
From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation
Much of the focus of human disease genetics is directed towards identifying nucleotide variants that contribute to disease phenotypes. This is a complex problem, often involving contributions from multiple loci and their interactions, as well as effects due to environmental factors. Although some di...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525162/ https://www.ncbi.nlm.nih.gov/pubmed/16848976 http://dx.doi.org/10.1186/1479-7364-2-6-383 |
_version_ | 1782253402133102592 |
---|---|
author | Stranger, Barbara E Dermitzakis, Emmanouil T |
author_facet | Stranger, Barbara E Dermitzakis, Emmanouil T |
author_sort | Stranger, Barbara E |
collection | PubMed |
description | Much of the focus of human disease genetics is directed towards identifying nucleotide variants that contribute to disease phenotypes. This is a complex problem, often involving contributions from multiple loci and their interactions, as well as effects due to environmental factors. Although some diseases with a genetic basis are caused by nucleotide changes that alter an amino acid sequence, in other cases, disease risk is associated with altered gene regulation. This paper focuses on how studies of gene expression variation might complement disease studies and provide crucial links between genotype and phenotype. |
format | Online Article Text |
id | pubmed-3525162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35251622012-12-19 From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation Stranger, Barbara E Dermitzakis, Emmanouil T Hum Genomics Review Much of the focus of human disease genetics is directed towards identifying nucleotide variants that contribute to disease phenotypes. This is a complex problem, often involving contributions from multiple loci and their interactions, as well as effects due to environmental factors. Although some diseases with a genetic basis are caused by nucleotide changes that alter an amino acid sequence, in other cases, disease risk is associated with altered gene regulation. This paper focuses on how studies of gene expression variation might complement disease studies and provide crucial links between genotype and phenotype. BioMed Central 2006-06-01 /pmc/articles/PMC3525162/ /pubmed/16848976 http://dx.doi.org/10.1186/1479-7364-2-6-383 Text en Copyright ©2006 Henry Stewart Publications |
spellingShingle | Review Stranger, Barbara E Dermitzakis, Emmanouil T From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation |
title | From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation |
title_full | From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation |
title_fullStr | From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation |
title_full_unstemmed | From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation |
title_short | From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation |
title_sort | from dna to rna to disease and back: the 'central dogma' of regulatory disease variation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525162/ https://www.ncbi.nlm.nih.gov/pubmed/16848976 http://dx.doi.org/10.1186/1479-7364-2-6-383 |
work_keys_str_mv | AT strangerbarbarae fromdnatornatodiseaseandbackthecentraldogmaofregulatorydiseasevariation AT dermitzakisemmanouilt fromdnatornatodiseaseandbackthecentraldogmaofregulatorydiseasevariation |